Calhoun Cardiology Center, School of Medicine, University of Connecticut School of Medicine, Farmington, Connecticut.
Department of Medicine, Boston University School of Medicine, Boston, Connecticut.
Am J Cardiol. 2024 Oct 15;229:28-35. doi: 10.1016/j.amjcard.2024.08.006. Epub 2024 Aug 10.
Sickle cell disease (SCD) is characterized by chronic anemia and recurrent ischemia-reperfusion episodes, which can lead to high-output heart failure. The impact of SCD on cardiac structure and function remains underinvestigated. We conducted a single-institution retrospective analysis of clinical and echocardiographic data from patients with hemoglobin SS SCD (SCD-SS) between January 2016 and June 2022. Patients with known heart failure, left ventricular (LV) ejection fraction <50%, moderate or severe valvular heart disease, congenital heart disease, established coronary artery disease, diabetes mellitus, hypertension, or coexistent lung disease were excluded. Compared with healthy controls (n = 28), patients with SCD-SS (n = 66) had a significantly higher left atrial (LA) volume index (35.7 vs 23.9 ml/m², p <0.001) and average E/e' (7.4 vs 6.5, p = 0.003) but lower average e' (12.3 vs 13.6 cm/s, p = 0.047) and LA reservoir strain (32.9% vs 42.4%, p <0.001). Patients with SCD-SS had higher LV end-diastolic (132.5 vs 104.1 ml, p <0.001) and LV end-systolic volumes (51.0 vs 43.8 ml, p = 0.017) with reduced LV global longitudinal strain (17.6% vs 20.0%, p <0.001). In addition, patients with SCD-SS showed reduced right ventricular (RV) global longitudinal strain (19.7% vs 22.8%, p <0.001) in the setting of normal RV tricuspid annular plane systolic excursion. Maximal systolic tricuspid regurgitation velocity (231 vs 202 cm/s, p <0.001) and right atrial area (16.6 vs 12.8 cm², p <0.001) were statistically greater in SCD-SS. Hemoglobin and hematocrit negatively correlated with LA volume index, average E/e', LV end-diastolic and LV end-systolic volumes. In conclusion, patients with SCD-SS had notable differences in cardiac chamber size and impaired LV, RV, and LA strain compared with healthy controls. Further investigations are needed to assess the impact of these variables on SCD clinical course and prognosis.
镰状细胞病(SCD)的特征是慢性贫血和反复发作的缺血再灌注发作,这可能导致高输出心力衰竭。SCD 对心脏结构和功能的影响仍未得到充分研究。我们对 2016 年 1 月至 2022 年 6 月期间患有血红蛋白 SS SCD(SCD-SS)的患者的临床和超声心动图数据进行了单中心回顾性分析。排除已知心力衰竭、左心室(LV)射血分数<50%、中度或重度瓣膜性心脏病、先天性心脏病、已确诊的冠心病、糖尿病、高血压或并存肺部疾病的患者。与健康对照组(n=28)相比,SCD-SS 患者(n=66)的左心房(LA)容积指数明显更高(35.7 vs 23.9 ml/m²,p<0.001)和平均 E/e'(7.4 vs 6.5,p=0.003),但平均 e'(12.3 vs 13.6 cm/s,p=0.047)和 LA 储备应变(32.9% vs 42.4%,p<0.001)较低。SCD-SS 患者的 LV 舒张末期(132.5 vs 104.1 ml,p<0.001)和 LV 收缩末期容积(51.0 vs 43.8 ml,p=0.017)更高,而 LV 整体纵向应变降低(17.6% vs 20.0%,p<0.001)。此外,在正常 RV 三尖瓣环平面收缩期位移的情况下,SCD-SS 患者的 RV 整体纵向应变降低(19.7% vs 22.8%,p<0.001)。SCD-SS 患者的最大收缩期三尖瓣反流速度(231 vs 202 cm/s,p<0.001)和右心房面积(16.6 vs 12.8 cm²,p<0.001)也显著增加。血红蛋白和血细胞比容与 LA 容积指数、平均 E/e'、LV 舒张末期和 LV 收缩末期容积呈负相关。总之,与健康对照组相比,SCD-SS 患者的心脏腔室大小存在显著差异,并且 LV、RV 和 LA 应变受损。需要进一步研究来评估这些变量对 SCD 临床过程和预后的影响。